corporate_banner_en

Venture debt

Venture debt

Venture debt

Finance for small, high-risk and incredibly innovative projects

The European Investment Bank has a unique take on a standard market product known as “venture debt”. The EIB aims to fill the market gap that afflicts European companies of medium size, where the financing needed is between EUR 7.5 million to EUR 50 million.

Here’s how it works

We commit sizeable amount of capital for the long-run which allows innovative companies to focus more on growing their business than constantly chasing investors. Steady repayment of the loan would drain the company’s coffers just when it needs to be investing in research and development. Alternatively, an equity investment would dilute the people who bore the risk of financing the early years of development.

Venture debt gives a unique advantage to strategic investors as the investee companies can use the capital to scale up the business. Additionally, the EIB’s venture debt provides a quality stamp and positive signaling effect, catalysing additional financing from other sources.

Listen to our podcast and hear what our experts have to say about the EU bank’s venture debt.

Why choose EIB’s venture debt

We provide capital to innovative, new companies without making them focus more on repaying their debts than on growing the business.

  • Our financing is not dilutive and it is complementary to equity investments
  • We commit large volumes of venture debt from EUR 7.5 million up to EUR 50 million
  • You can benefit from longer repayment periods of 5 years with 2-3 year availability periods
  • You can focus on product development not on raising funds
  • We are a triple-A investor with a long-term strategic view
  • We have a hands-off approach with no direct involvement in daily management

Discover some of our deals

So far over 40 innovative businesses have benefited from EIB’s venture debt. Here’s what it means for a few of them:

Prosthetic limbs from a 3D printer

Prosthetic limbs from a 3D printer

Ultimaker, a Dutch company, pushes the boundaries of 3D printing technology and creates a lifeline for amputees in developing countries.

Buildings get a skin that produces electricity

Buildings get a skin that produces electricity

What if you could cover your home or office with a thin film that acted like a giant solar panel? Heliatek, an innovative German company, brings solar energy generation to the heart of the city.

Supercapacitors a better way to store energy

Supercapacitors a better way to store energy

The key ingredient in powerful devices for storing energy has been charred coconut. Now Skeleton technologies, a company in icy Estonia, has figured out how to make a supercapacitor without tropical fruit.

Innovative companies supported so far

Venture debt targets European companies with up to 3 000 employees in the field of Biotech & Life sciences, Software & ICT, Engineering & Automation, Renewables & Clean tech

Kiosked
Qwant
eVision
Gigaclear
InRiver
Cellnovo
Innocoll
Biosurfit
Jennewein
New Icon
Nosto
Curetis
Hyperoptic
Enevo
Valneva
Canatu
Upstream
Skeleton technologies
Archos
Flexenclosure
Ultimaker
AMRYT Pharma
Medneo
magforce, the nanomedicine company
Creta farms
Transgene
MOBIDIAG
STAT diagnostica
iZettle
Sunpartner technologies
Fineos
Frosmo
Cavidi
Apeiron biologics
Biofrontera
MariaDB Foundation
Heliatek
Adamo
Every Angle
Olmix Group
Electro power systems group
Science4you

Get finance

Are you looking to accelerate the growth
of your innovative business?

Download the eligibility form

All inquiries and questions can be sent to
venturedebt@eib.org


The venture debt team will process applications as soon as possible. The time between the first contact with the EIB and the signature of a financing contract will typically take 3-6 months, depending on whether you have provided all the information needed. Please, note that the selection process is very rigorous and ultimate signature depends on obtaining all necessary approvals and clearances.




 Print